Old Web
English
Sign In
Acemap
>
authorDetail
>
Kevin McDonagh
Kevin McDonagh
Vanderbilt University
Immunology
Medicine
Carfilzomib
Progressive disease
Ibrutinib
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study
2015
Blood
Ajai Chari
Saurabh Chhabra
Saad Z. Usmani
Sarah Larson
Ruben Niesvizky
Jeffrey Matous
Cristina Gasparetto
Beata Holkova
Matthew Lunning
Jason Valent
Larry D. Anderson
Chatchada Karanes
Long Kwei
Lipo Chang
Thorsten Graef
Elizabeth Bilotti
Kevin McDonagh
Show All
Source
Cite
Save
Citations (7)
The Bruton's tyrosine kinase inhibitor ibrutinib in combination with carfilzomib in patients with relapsed or relapsed and refractory multiple myeloma: initial results from a multicenter phase 1/2b study
2015
Clinical Lymphoma, Myeloma & Leukemia
Saurabh Chhabra
Saad Z. Usmani
Sarah Larson
Ruben Niesvizky
Jeffrey Matous
C. Gasparetto
Beata Holkova
Matthew A. Lunning
Jason Valent
Larry D. Anderson
Chatchada Karanes
Long Kwei
Lipo Chang
Thorsten Graef
Elizabeth Bilotti
Kevin McDonagh
Show All
Source
Cite
Save
Citations (1)
Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) + Rituximab ± Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas
2013
Blood
Daniel O. Persky
Daruka Mahadevan
Thomas P. Miller
Soham D. Puvvada
Kevin McDonagh
John Hayslip
Steven I. Park
Jia Ruan
Peter Rosen
Swaminathan Padmanabhan Iyer
Alexandra Stefanovic
Bin Zhang
Xiaofei Zhou
Claudio Dansky Ullmann
E. Jane Leonard
Jonathan W. Friedberg
Show All
Source
Cite
Save
Citations (7)
Developing Mathematical Thinking [by Ann Floyd]
1983
Kevin McDonagh
Show All
Source
Cite
Save
Citations (0)
1